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Abstract
Asthma is a complex phenotype influenced by genetic and environmental factors. We conducted a genome-wide
association study (GWAS) with 938 Japanese pediatric asthma patients and 2,376 controls. Single-nucleotide polymorphisms
(SNPs) showing strong associations (P,1610
28) in GWAS were further genotyped in an independent Japanese samples
(818 cases and 1,032 controls) and in Korean samples (835 cases and 421 controls). SNP rs987870, located between HLA-
DPA1 and HLA-DPB1, was consistently associated with pediatric asthma in 3 independent populations (Pcombined=
2.3610
210, odds ratio [OR]=1.40). HLA-DP allele analysis showed that DPA1*0201 and DPB1*0901, which were in strong
linkage disequilibrium, were strongly associated with pediatric asthma (DPA1*0201: P=5.5610
210, OR=1.52, and
DPB1*0901: P=2.0610
27, OR=1.49). Our findings show that genetic variants in the HLA-DP locus are associated with the
risk of pediatric asthma in Asian populations.
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Introduction
Asthma is the most common chronic disorder in children, and
asthma exacerbation is an important cause of childhood morbidity
and hospitalization. The prevalence of childhood asthma in Japan
is 5.0% among school children in 2006 [1], and an estimated 300
million people worldwide have asthma [2]. Asthma is character-
ized by airway hyperresponsiveness and inflammation, tissue
remodeling, and airflow obstruction. Infiltration of lymphocytes,
mast cells, and eosinophils in the airways cause airway
inflammation, and T helper (Th) type 2 cytokines play crucial
roles in orchestrating the inflammatory responses; thus, asthma is
considered a Th2-type immune disease.
Previously conducted genome-wide association studies (GWAS)
for asthma identified association with the loci on chromosomes
17q21 (ORMDL3 for Caucasian pediatric asthma, odds ratio
(OR)=1.45, P=1 610
210) [3], 5q21 (PDE4D for pediatric asthma,
OR=0.6, P=4.7610
27) [4], 9q21.31 (TLE4 for Hispanic
pediatric asthma, OR=0.6, P=6.8610
27) [5], and 1q31
(DENND1B for Europeans and African ancestries [6], OR=0.77
and 1.41, respectively; combined P=1.7610
213). A GWAS for
severe asthma identified association with the region between
PLoS Genetics | www.plosgenetics.org 1 July 2011 | Volume 7 | Issue 7 | e1002170RAD50 and IL5 on chromosome 5q (OR=1.64, P=3.0610
27)
and HLA-DR/DQ (OR=0.68, P=9.6610
26), but they did not
include a replication dataset [7]. Recently, Moffatt et al. conducted
a large-scale GWAS in Caucasian populations and identified 6 loci
(IL18R1, HLA-DQ, IL33, SMAD3, GSDMB/GSDMA, and IL2RB)
associated with asthma [8].
In the present study, we conducted the first GWAS in Asian
population for pediatric asthma by using Illumina Human-
Hap550/610-Quad BeadChip (Illumina, San Diego, USA).
Results
GWAS analysis
The GWAS flow chart is shown in Figure 1. We analyzed
450,326 SNPs in 938 cases and 2,376 controls, using standard
quality control practices (Table S1). The genotypes in cases and
controls were compared using the Cochran–Armitage trend test
(Figure 2). There was only minor inflation of the genome-wide
statistical results owing to population stratification (genomic
control (lGC)=1.048; Figure 3). Five SNPs (rs3019885,
rs987870, rs2281389, rs2064478, and rs3117230) showed strong
association with pediatric asthma with P,1610
28. Of these,
rs2064478 and rs3117230 were in complete linkage disequilibrium
(LD) (r
2=1) with rs2281389. In order to validate the results of the
GWAS, we tested the remaining 3 SNPs (rs3019885, rs987870,
and rs2281389) in 2 independent replication cohorts comprising
Asians (Japanese and Koreans), considering P,0.05 as significant
replication.
Of these 3 SNPs, significant associations were noted at rs987870
in both cohorts (Table 1). To merge the findings of these studies,
we conducted meta-analysis with a fixed-effects model by using the
Mantel–Haenszel method. As shown in Table 1, the Mantel–
Haenszel P value of 2.3610
210 was noted for rs987870
(OR=1.40, confidence interval (CI)=1.26–1.55).
HLA-DP association with pediatric asthma
The rs987870 is located between HLA-DPA1 and HLA-DPB1.
Genotype imputation using MACH [9] revealed association
between asthma and the SNPs that were in strong LD with
rs987870 (Figure 4, Table S2). Moreover, rs987870 C allele was in
complete LD with DPA1*0201 (r
2=1). We determined HLA-DPA1
genotypes by using direct sequencing and MACH imputation of
the data from 1135 cases and 2376 controls and found that
DPA1*0201 was strongly associated with pediatric asthma
(P=5.2610
210, OR=1.52, Table 2). Then, we determined the
HLA-DPB1 genotypes in 1135 cases and 2296 controls and found
that DPB1*0901 was associated with pediatric asthma
(P=2.0610
27, OR=1.49, Table 3). DPB1*0901 was in strong
LD with DPA1*0201 and rs987870 C allele (D prime=0.93).
Because more than 90% of pediatric asthma patients were allergic
to house dust mites, it is possible that the association was due to
IgE reactivity (sensitization) against mites. We performed an
association study for mite sensitization using independent adult
subjects without allergic respiratory diseases such as asthma and
perennial allergic rhinitis (367 subjects with house dust mite-
specific IgE and 1633 subjects without mite-specific IgE). Subjects
with house dust mite-specific IgE were non-allergic in terms of
symptoms but possessed mite-specific IgE. Subjects without mite-
specific IgE did not exhibit allergic symptoms. We did not find an
association between rs987870 and mite sensitization (P=0.54,
OR=1.07, Table S3).
Discussion
Our GWAS in Asian populations found HLA-DP as suscepti-
bility gene for pediatric asthma. Majority of pediatric asthmas are
atopic (i.e., familial tendency to produce IgE antibodies against
common environmental allergens) and possess specific IgE against
the house dust mite. Mite sensitization is more prevalent in Asia
than in Europe and is observed in 39% of the general adult
population in Japan [10]. High prevalence of mite sensitization in
asthmatic children has also been reported in Taiwan, where
94.2% of children with asthma are sensitized against Dermatoph-
agoides pteronyssinus [11]. However, only a small subset of subjects
with house dust allergy develop asthma [12].
We performed an independent association study for mite
sensitization in adult subjects without allergic respiratory diseases
and did not find an association between rs987870 and mite
sensitization without symptoms. If the relative risk for mite
sensitization in the individuals carrying a putative risk allele was
1.4 and the allele frequency was 0.15 compared to that in
individuals without the allele, the statistical power of the sample
size for mite sensitization study was 0.92 at an alpha level of 0.05.
These results suggested that DPA1*0201 and DPB1*0901 may be
associated with asthma rather than IgE production against house
dust mite.
The association signal was stretched in the region of HLA-DPB2,
collagen, type XI, alpha 2 (COL11A2), and Retinoid X receptor
beta (RXRB) (Figure 4). Because of LD in this region, it is difficult
to specifically identify causative variants. HLA-DPB2 is a
pseudogene. COL11A2 encodes a component of type XI collagen
called the pro-alpha2(XI) chain. Mutations in COL11A2 have been
associated with non-syndromic deafness, otospondylomegaepiphy-
seal dysplasia, Weissenbacher-Zweymu ¨ller syndrome, and Stickler
syndrome (OMIM ID *120290). RXRB belongs to the RXR
family and is involved in mediating the effects of retinoic acid.
RXRB forms a heterodimer with the retinoic acid receptor and
thus preferentially increases its DNA binding and transcriptional
activity at promoters containing retinoic acid [13]. All SNPs
showing strong association with asthma (P,1610
210) were
located in introns or intergenic regions. LD of these associated
SNPs with rs987870 was not strong; therefore, it is likely that the
functional effect is due to DPA1*0201 and DPB1*0901.
Author Summary
Asthma is the most common chronic disorder in children,
and asthma exacerbation is an important cause of
childhood morbidity and hospitalization. Here, taking
advantage of recent technological advances in human
genetics, we performed a genome-wide association study
and follow-up validation studies to identify genetic
variants for asthma. By examining 6,428 Asians, we found
rs987870 and HLA-DPA1*0201/DPB1*0901 were associated
with pediatric asthma. The association signal was stretched
in the region of HLA-DPB2, collagen, type XI, alpha 2
(COL11A2), and Retinoid X receptor beta (RXRB), but strong
linkage disequilibrium in this region made it difficult to
specifically identify causative variants. Interestingly, the
SNP (or the HLA-DP allele) associated with pediatric
asthma (Th-2 type immune diseases) in the present study
confers protection against Th-1 type immune diseases,
such as type 1 diabetes and rheumatoid arthritis.
Therefore, the association results obtained in the present
study could partially explain the inverse relationship
between asthma and Th-1 type immune diseases and
may lead to better understanding of Th-1/Th-2 immune
diseases.
HLA-DP Association for Pediatric Asthma
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significantly decreased in patients with allergic asthma in Mulatto
population (an admixture population of European and African
ancestries) [14]. Apart from the study of Caraballo et al., the
association between HLA-DP alleles and asthma was restricted to
occupational [15] or aspirin-induced asthma [16]. Howell et al.
reported associations between HLA-DR genotype and asthma and
between HLA-DPA1*0201 and IgE specific to grass pollen mix and
the pollen allergen Phl p 5 [17]. Grass pollen allergy is not a major
cause of asthma in Japan [18]; therefore, the HLA-DPA1*0201
association in the present study was less likely to be due to
sensitization to grass pollen.
DPA1*0201 has also been reported to be positively associated
with lower levels of rubella-induced antibodies [19], cytokine
immune responses against measles vaccine [20], and ulcerative
colitis [21], and negatively associated with type 1 diabetes [22].
Figure 1. Flow chart of the present study.
doi:10.1371/journal.pgen.1002170.g001
Figure 2. P values of GWAS. The Manhattan plot shows the Cochran–Armitage trend test P values for 938 cases of asthma and 2,376 controls;
450,326 autosomal SNPs were considered in the study. The dashed line indicates the genome-wide significance level (P,56102
8).
doi:10.1371/journal.pgen.1002170.g002
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[23], non-permissive mismatches for hematologic stem cell
transplantation [24], ulcerative colitis [21], and Takayasu’s
arteritis [25]. HLA-DP molecules present short peptides of largely
exogenous origin to CD4-positive helper T cells and other T cells,
leading to subsequent immunological responses. T cells recognize
complex formation between a specific HLA type and a particular
antigen-derived epitope. Therefore, HLA molecules capable of
binding a particular epitope can restrict T cell induced-immune
responses, leading to association between particular HLA types
and immune-related diseases. Type 1 diabetes is a Th-1 type
immune disease. Varney et al. studied 1,771 type 1 diabetes
multiplex families, analyzing them by the affected family-based
control method [26], and found that DPA1*0201 has a protective
effect on the development of type 1 diabetes (adjusted P=5 610
24,
OR 0.7) [22]. Epidemiologic studies have associated type 1
diabetes with lower prevalence of asthma and other allergic
diseases [26,27]. Also, the previous GWAS of rheumatoid arthritis,
other Th-1 type immune disease, has shown that rs987870 C allele
confers protection against rheumatoid arthritis [28]. These
findings suggest that HLA-DPA1*0201 could determine Th1/
Th2 dominance and could partially explain the inverse relation-
ship between asthma and Th-1 type immune diseases.
Previous GWAS involving European, Mexican, and African
populations showed association of asthma with SNPs located in
several newly discovered genes. Our GWAS dataset supported an
association between identical SNPs reported in ORMDL3/
GSDMB/GSDMA, IL5/RAD50/IL13, HLA-DR/DQ, and SMAD3
and pediatric asthma (P,0.05, Table S4). Two asthma GWA
studies revealed an association of HLA-DQ with pediatric/adult
asthma in Caucasians [7,8]. HLA-DQ, like HLA-DP, is an ab
heterodimer of the MHC Class II type. Like HLA-DP, HLA-DQ
recognizes and presents foreign antigens, but is also involved in
recognizing common self-antigens and presenting those antigens to
the immune system.
We failed to replicate the top SNPs of PDE4D, TLE4,
DENND1B, IL18R1, and IL2RB that were reported in the original
articles, but several SNPs in the regions surrounding PDE4D and
IL2RB showed significant association when we set the significance
level at P=0.05 (Table S4). The different LD patterns/allele
frequencies observed in PDE4D and IL2RB in Asians and
Caucasians may explain the different SNP associations observed
Figure 3. Quantile–quantile (Q–Q) plot of GWAS for pediatric asthma. The results of the Cochrane–Armitage trend P are plotted as dots and
the line y=x is in red. The horizontal and vertical lines represent expected P values under null distribution and observed P values, respectively.
doi:10.1371/journal.pgen.1002170.g003
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SNP Nearest Allele
a Samples MAF MAF OR (95%CI)
b P
c P
e
Gene (asthma) (control)
rs3019885 SLC30A8 T/G GWAS 0.41 0.31 1.55(1.39–1.73) 1.3610
214
First replication (Japanese) 0.34 0.30 1.21(1.05–1.39) 8.7610
23
Second replication (Koreans) 0.27 0.26 1.075(0.88–1.31) 4.7610
21
Meta analysis (HM)
d 1.34(1.24–1.45) 5.0610
213 0.0011
rs987870 HLA-DPB1 T/C GWAS 0.19 0.14 1.51(1.31–1.74) 7.5610
29
First replication (Japanese) 0.17 0.14 1.26(1.05–1.50) 1.2610
22
Second replication (Koreans) 0.12 0.10 1.34(1.01–1.76) 4.1610
22
Meta analysis (HM)
d 1.40(1.26–1.55) 2.3610
210 0.33
rs2281389 HLA-DPB1 T/C GWAS 0.23 0.17 1.47(1.29–1.68) 8.5610
29
First replication (Japanese) 0.20 0.17 1.20(1.02–1.42) 2.9610
22
Second replication (Koreans) 0.08 0.08 1.085(0.80–1.48) 6.1610
21
Meta analysis (HM)
d 1.33(1.20–1.47) 1.4610
28 0.076
aThe former allele represents the major allele.
bOdds ratio and 95% confidence interval (CI) of minor allele.
cP values of allelic model.
dMeta-analysis using Mantel-Haenszel approach.
eP values for heterogeneity test.
doi:10.1371/journal.pgen.1002170.t001
Figure 4. Association findings of genotyped (squares) and imputed (circles) SNPs in the HLA-DP region. SNP rs987870, which
consistently showed an association with pediatric asthma in 3 independent populations, is located in the LD block between HLA-DPA1 and HLA-DPB1.
The color intensity of each symbol reflects the extent of LD with rs987870: from red (r
2.0.8) to blue (r
2,0.2). The physical positions are based on
NCBI build 36 of the human genome.
doi:10.1371/journal.pgen.1002170.g004
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polymorphic in the Asian population.
There were several limitations of the present GWAS. The
controls for the GWAS and 1
st replication samples were from adult
populations. Information regarding history of asthma in early
childhood or other asthma-related information (i.e., status of
allergic sensitization and lung function) was not collected for these
controls. Therefore, we cannot exclude the possibility that our
control samples may include subjects who outgrew asthma. The
prevalence of pediatric asthma in Japan is around 5%; therefore,
our GWAS samples have reduced power compared with that of
selected controls. In the 1
st replication Japanese controls, subjects
with present and past history of allergic diseases were excluded,
and Korean controls in the 2
nd replication were non-allergic
pediatric controls (Table S5).
The genomic control value in the present study was 1.053,
indicating minor population stratification. The Japanese popula-
tion comprises 2 clusters (Hondo and Ryukyu; Hondo is the
mainland of Japan and Ryukyu is the name of the island south of
Japan). We performed principal component analysis using
EIGENSTRAT software [29] to identify subjects belonging to
Ryukyu. Because 2nd or 3rd generation Chinese live in Japan, and
the genetic population structure in Chinese differs from that in
Japanese, we also performed principal component analysis to
exclude Chinese subjects. Although hidden population stratifica-
tion may exist, its influence on the final results is not expected to
be significant.
rs3019885 is located in intron 2 of solute carrier family 30
(SLC30A8), and showed strong association in the GWAS
population. The association was replicated in the independent
Japanese samples, but not in the Korean population. SLC30A8 is
a zinc efflux transporter expressed at high levels only in the
pancreas; the GWAS revealed that variants of SLC30A8 are
associated with type 2 diabetes [30]. Japanese and Koreans are
genetically close but we cannot exclude the possibility that the
association of rs3019885 with pediatric asthma is population
specific.
In conclusion, we performed the first GWAS in Asian
population for pediatric asthma and found that DPA*0201/
DPB1*0901 is strongly associated with pediatric asthma. The
association with the HLA-DP locus emphasizes the importance of
the HLA-class II molecules on the biological pathways involved in
the etiology of pediatric asthma, and suggests that HLA-DP can be
a therapeutic target for asthma.
Materials and Methods
Ethical statement
The study was approved by the institutional review board and
the ethics committee of each institution. Written informed consent
was obtained from each participant in accordance with institu-
tional requirements and the Declaration of Helsinki Principles.
Subject participants
Characteristics of pediatric asthma cases and controls are
summarized in Table S5.
GWAS population. All subjects with asthma were child or
child-onset (,15 years old) asthmatics in Japan. Patients were
recruited from 3 pediatric hospitals and 1 pediatric clinic, and the
diagnosis of the asthma in all patients was confirmed by specialists
in pediatric allergology on the basis of the criteria of the National
Institutes of Health, USA, with minor modifications.
The control cases for the GWAS were healthy Japanese adult
subjects from Osaka (n=964), Tokyo (n=660), and Ibaraki
Table 2. HLA-DPA1-rs987870 Haplotype analysis of pediatric asthma.
DPA1 rs987870 asthma control Odds ratio (95%CI) P values
DPA1*0103 T 858(38%) 1866(39%) 0.98 (0.85–1.05) 0.29
DPA1*0201 C 439 (19%) 650 (14%) 1.52 (1.33–1.74) 5.5610
210
DPA1*0202 T 957(42%) 2223(47%) 0.83 (0.75–0.92) 0.00046
DPA1*0401 T 3 (0.1%) 5 (0.1%) 1.26 (0.30–5.28) 0.75
doi:10.1371/journal.pgen.1002170.t002
Table 3. HLA-DPB1 allele frequency in pediatric asthma and controls.
Allele Asthma Control 1 Control 2 Asthma vs Control 1 Asthma vs Control 2 Asthma vs Control 1+2
n=1135 n=794 n=1475 P OR (95%CI) P OR (95%CI) P OR (95%CI)
DPB1*05:01 34.4% 36.5% 38.0% 0.18 0.91(0.80–1.04) 0.007 0.85(0.76–0.96) 0.013 0.87(0.79–0.97)
DPB1*02:01 22.4% 24.2% 24.3% 0.19 0.90(0.78–1.05) 0.11 0.89(0.79–1.02) 0.09 0.90(0.80–1.02)
DPB1*09:01 14.5% 10.1% 10.3% 5.5610
25 1.51(1.23–1.84) 3.4610
26 1.48(1.25–1.75) 2.0610
27 1.49(1.28–1.74)
DPB1*04:02 10.0% 9.2% 9.6% 0.38 1.10(0.89–1.37) 0.57 1.05(0.88–1.27) 0.43 1.07(0.90–1.27)
DPB1*04:01 4.8% 7.1% 5.0% 0.0019 0.65(0.50–0.86) 0.64 0.94(0.73–1.21) 0.08 0.82(0.65–1.03)
DPB1*03:01 4.9% 4.7% 4.0% 0.76 1.05(0.78–1.41) 0.11 1.24(0.95–1.62) 0.21 1.17(0.92–1.48)
DPB1*02:02 3.7% 3.2% 3.4% 0.46 1.14(0.80–1.63) 0.61 1.08(0.80–1.45) 0.49 1.10(0.84–1.45)
DPB1*13:01 1.6% 1.5% 2.1% 0.85 1.05(0.62–1.77) 0.18 0.75(0.50–1.14) 0.38 0.84(0.57–1.24)
DPB1*14:01 1.8% 1.7% 1.4% 0.88 1.04(0.63–1.70) 0.258 1.28(0.83–2.01) 0.39 1.19(0.80–1.76)
doi:10.1371/journal.pgen.1002170.t003
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GWAS, we genotyped 978 cases with pediatric asthma and 2402
controls using Illumina HumanHap550v3/610-Quad Genotyping
BeadChip (Illumina, San Diego, USA). Subjects from Osaka and
Ibaraki were randomly selected from residents of Suita city and
Tone town, respectively. Subjects from Tokyo were hospital
workers from Keio University Hospital, Tokyo. We excluded
samples considered duplicated, related (first- or second-degree
relatives), or belonging to Han Chinese or Ryukyu. In total, 938
cases and 2376 controls were considered for further analysis.
First replication population (Japanese). We recruited 818
subjects with childhood atopic asthma from the Osaka Prefectural
Medical Center for Respiratory and Allergic Diseases, Dokkyo
University School of Medicine, National Research Institute for
Child Health & Development, National Sagamihara Hospital, and
Chiba University Hospital. All subjects with bronchial asthma
were diagnosed according to the criteria of the National Institutes
of Health (National Heart, Lung, and Blood Institute, National
Institutes of Health, 1991) by physicians who were asthma
specialists [32,33]. After the exclusion of individuals who had
been diagnosed with asthma, atopic dermatitis, or nasal allergies
by physicians’ interviews, 825 healthy individuals were recruited
from the Midousuji Rotary Club [32,33]. Two hundred and seven
control subjects who never had the symptoms of allergic rhinitis/
asthma and did not show any sensitization to 7 common
aeroallergens were recruited from Fukui [34].
Second replication population (Korean). Patients with
pediatric asthma were enrolled at Asan Medical Center,
University of Ulsan College of Medicine, Seoul, Korea. The
control subjects were age-matched children with no history of
asthma or other allergic diseases, negative skin prick test, and
normal total IgE values (,100 IU/mL) recruited from the same
district (Seoul). Total of 835 cases and 421 controls participated in
this study. The details of the patients and controls were described
in a previous study [35].
Subjects for IgE sensitization against house dust
mite. General populations for mite sensitivity study were
recruited from Fukui [10] and Tsukuba in Japan. Total and
specific IgE levels (produced in response to Japanese cedar,
Dermatophagoides, Dactylis glomerata, Ambrosia artemisiifolia, Candida
albicans, and Aspergillus) were measured using the CAP-RAST
method (for Fukui samples; Pharmacia Diagnostics AB, Uppsala,
Sweden) or MAST-26 (for Tsukuba samples; Hitachi Chemical
Co. Ltd., Tokyo, Japan). Positive sensitization against house dust
mite was defined as specific IgE levels against the house dust mite
(Dermatophagoides farinae or Dermatophagoides pteronyssinus) greater than
or equal to 0.70 IU/ml (class 2) or lumicount greater than 2.76
(class 2). Subjects with asthma (current or past) or perennial
allergic rhinitis were excluded from the analysis. Sensitized
subjects (Mite-positive) were non-allergic in terms of symptoms
but possessed mite-specific IgE. Non-sensitized subjects (Mite-
negative) did not show any allergic symptoms and did not have
mite-specific IgE.
Subjects for HLA-DPA1 typing. Cases with asthma included
938 subjects used in GWAS analysis and 207 Japanese subjects
with child- or child-onset (,15 years) asthmatics recruited in
Tsukuba. The diagnosis of asthma in all patients was confirmed by
specialists in pediatric allergology on the basis of the criteria of the
National Institutes of Health, USA, with minor modifications. The
control subjects were 2378 subjects that were used in GWAS
analysis. Because most of the DNA from the GWAS controls was
not available for genotyping, and we found that imputation of the
HLA-DPA1 allele using GWAS results was highly accurate (error
rate, 0.003), we decided to genotype the HLA-DPA1 allele by direct
sequencing and imputation. Among the subjects for HLA-DPA1
genotyping (1135 cases and 2376 controls), genotyping of 383
subjects was performed by direct sequencing and genotyping of the
remaining 3128 samples was performed by imputation.
Subjects for HLA-DPB1 typing. Cases with asthma included
938 subjects used in GWAS analysis and 207 Japanese subjects
with child- or child-onset (,15 years) asthmatics; the same as those
used in HLA-DPA1 typing. The control 1 subjects for HLA-DPB1
typing were 794 healthy adult subjects from Tokyo and 399
subjects were the same as those in GWAS. The control 2 subjects
(n=1475) were general datasets from Japanese population samples
publically available at http://www.hla.or.jp/hapro/top.html.
Because most of the DNA from the GWAS controls was not
available for genotyping, and the imputation of the DPB1 allele
using the GWAS results was not possible, we used 794 healthy
adult subjects from Tokyo and 399 subjects from the GWAS for
DPB1 genotyping (Control 1). The control 2 subjects (n=1475)
were general datasets from Japanese population samples publically
available at http://www.hla.or.jp/hapro/top.html. The status of
asthma or other allergic diseases for these samples is not available.
Genotyping
Genotyping for GWAS was performed using the Illumina
HumanHap550v3/610-Quad Genotyping BeadChip (Illumina),
as per manufacturer’s instruction.
In replication analyses, genotyping of each individual was
performed with the TaqMan genotyping system (Applied
Biosystems) on an ABI PRISM 7900HT Sequence Detection
System (Applied Biosystems). PCR was performed on a 384-well
format, and automatic allele calling was performed using ABI
PRISM 7900HT data collection and analysis software, version
2.2.2 (Applied Biosystems).
HLA-DPB1 genotyping of 1135 cases, 794 controls (control 1)
and 1475 controls (control 2) were performed with the WAKFlow
HLA typing kit (Wakunaga, Hiroshima, Japan), as per manufac-
turer’s instruction. First, the target DNA was amplified by
polymerase chain reaction (PCR) with biotinylated primers
specifically designed for each HLA-DPB1 locus. Then, the PCR
product was denatured and hybridized to complementary
oligonucleotide probes immobilized on fluorescent-coded micro-
sphere beads. Concurrently, the biotinylated PCR product was
labeled with phycoerythrin-conjugated streptavidin and immedi-
ately examined with the Luminex 100 system (Luminex, Austin,
TX). Genotype determination and data analysis were performed
with the WAKFlow typing software (Wakunaga).
HLA-DPA1 genotyping was performed with direct sequencing of
exon 2 with forward primer 59-TCAGGATGCCCAGACTTT-
CAA-39 and reverse primer 59-CAGGGGGCACTTAGGC-
TTCC-39, and with the sequencing primer 59-TCAGGATGCC-
CAGACTTTCAA-39 using the BigDye Terminator v.1.1 Cycle
Sequencing Kit (Applied Biosystems) on an ABI PRISM 3130
Genetic Analyzer (Applied Biosystems).
Statistical analysis
In the GWAS, we examined the potential genetic relatedness on
the basis of pairwise identity by state for all of the successfully
genotyped samples using the EIGENSTRAT software [29]. In the
GWAS, we genotyped 978 cases with pediatric asthma and 2402
controls using Illumina HumanHap550v3/610-Quad Genotyping
BeadChip (Illumina, San Diego, USA). Samples of duplicated
(identical individual or monozygotic twin), first-, second-, and
third-degree pairs were detected, and the individual with a lower
call rate was excluded from further analysis. PCA was performed,
and the results were combined with those obtained for our in-
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Kabata et al. characterized the Japanese population structure using
the genotypes for 140,387 SNPs in 7003 Japanese individuals,
along with 60 European, 60 African, and 90 East-Asian
individuals, in the HapMap project and found that the Japanese
population is composed of 2 clusters (Hondo and Ryukyu) [36].
Hondo is the biggest island of Japan, and the island of Ryukyu is
located in southern Japan. Also, we have 2nd or 3rd generation
Chinese living in Japan, and Chinese present a different genetic
population structure from Japanese. Therefore, we excluded
samples belonging to Han Chinese or Ryukyu, and 938 cases
and 2376 controls were considered for further analysis.
Cluster plots of SNPs were checked by visual inspection and
SNPs with ambiguous calls were excluded. We excluded SNPs
with a low genotyping rate (,90%), minor allele frequency less
than 0.01 in either pediatric asthma cases or controls, or with
Hardy-Weinberg equilibrium P value,10
24 in controls. Finally,
450,326 SNPs were used for the GWAS. Details regarding the
exact number of remaining SNPs after applying each quality
control criterion are available in Table S1.
The genomic control inflation factor (lGC), defined as the
median association test statistic across all SNPs divided by its
expected value, was calculated by the method proposed by Devlin
et al. [37]. GWAS and replication analyses were performed using
the Cochran–Armitage trend test and x
2 test. The meta-analysis
was performed with the Mantel–Haenszel approach as a fixed-
effects model [38]. All statistical findings were reported without
correction. The results of GWAS were plotted with GWAS GUI
v0.0.2 [39]. HLA-DP region was plotted with LocusZoom [40].
The power calculation was performed with Genetic Power
Calculator [41]. Quantile-quantile (Q-Q) plot was plotted with
ggplot2 package [42] in R version 2.10.0 (http://www.r-project.
org/).
Imputation of genotypes in the DP region was performed with
MACH version 1.0 [9] with 1000 Genome Project data (1000G 2010-
6 release, http://www.sph.umich.edu/csg/yli/mach/download/
1000G-2010-06.html).
HLA-DPA1 allele imputation
The HLA-DP region was in strong linkage disequilibrium and
some DPB1 alleles were known to be linked with particular DPA1
alleles. First, we imputed HLA-DPA1 alleles by using the actual
genotype data of samples obtained from Illumina Human-
Hap550v3/610-Quad (Illumina) and 1000 Genome Project data
of Asian origin (JPT+CHB) (http://www.sph.umich.edu/csg/
abecasis/MaCH/download/1000G-2010-06.html). The accuracy
of the imputated data was confirmed by direct sequencing. The
error rate of imputation was 1/352 (0.003).
Supporting Information
Table S1 Number of remaining SNPs after applying each
quality control criterion.
(XLS)
Table S2 SNPs that are strong linkage disequilibrium (r
2.0.9)
with rs987870.
(XLS)
Table S3 Association analysis for mite IgE sensitization.
(XLS)
Table S4 Genotyping data of the Japanese pediatric asthma
GWAS.
(XLS)
Table S5 Characteristics of cases and controls.
(XLS)
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